1. Home
  2. AUPH vs PL Comparison

AUPH vs PL Comparison

Compare AUPH & PL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • PL
  • Stock Information
  • Founded
  • AUPH 1993
  • PL 2010
  • Country
  • AUPH Canada
  • PL United States
  • Employees
  • AUPH N/A
  • PL N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • PL Aerospace
  • Sector
  • AUPH Health Care
  • PL Industrials
  • Exchange
  • AUPH Nasdaq
  • PL Nasdaq
  • Market Cap
  • AUPH 999.8M
  • PL 947.7M
  • IPO Year
  • AUPH 1999
  • PL N/A
  • Fundamental
  • Price
  • AUPH $8.18
  • PL $3.38
  • Analyst Decision
  • AUPH Strong Buy
  • PL Buy
  • Analyst Count
  • AUPH 2
  • PL 11
  • Target Price
  • AUPH $11.50
  • PL $5.53
  • AVG Volume (30 Days)
  • AUPH 1.3M
  • PL 4.0M
  • Earning Date
  • AUPH 05-05-2025
  • PL 06-05-2025
  • Dividend Yield
  • AUPH N/A
  • PL N/A
  • EPS Growth
  • AUPH N/A
  • PL N/A
  • EPS
  • AUPH 0.04
  • PL N/A
  • Revenue
  • AUPH $235,133,000.00
  • PL $244,352,000.00
  • Revenue This Year
  • AUPH $11.86
  • PL $14.08
  • Revenue Next Year
  • AUPH $24.96
  • PL $21.49
  • P/E Ratio
  • AUPH $204.50
  • PL N/A
  • Revenue Growth
  • AUPH 33.97
  • PL 10.72
  • 52 Week Low
  • AUPH $4.86
  • PL $1.67
  • 52 Week High
  • AUPH $10.67
  • PL $6.71
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 56.33
  • PL 47.52
  • Support Level
  • AUPH $7.92
  • PL $2.92
  • Resistance Level
  • AUPH $8.32
  • PL $3.33
  • Average True Range (ATR)
  • AUPH 0.34
  • PL 0.30
  • MACD
  • AUPH 0.07
  • PL 0.06
  • Stochastic Oscillator
  • AUPH 90.64
  • PL 63.44

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About PL Planet Labs PBC

Planet Labs PBC is an Earth-imaging company. The company provides daily satellite data that helps businesses, governments, researchers, and journalists understand the physical world and take action.

Share on Social Networks: